These results suggested that patients with ccGBMs have a longer survival time and progression-free survival if the tumor is located in the anterior or posterior of the corpus callosum and have an IDH1 mutation, the en-bloc technique was applied, or supramaximal resection was achieved. The gene discussed is IDH1; the disease is neoplasm.